NCT00273754View on ClinicalTrials.gov

The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Sleep Apnea, ObstructiveTonsillectomyAdenoidectomyPostoperative Complications
Interventions
DRUG

Caffeine

Children in group one will receive caffeine benzoate 20 mg/kg i.v., which is equal to a 10 mg/kg caffeine base.

DRUG

Placebo

Children in group two will receive an amount of normal saline equal to Caffeine

Trial Locations (1)

77030

University of Texas, Health Science Center at Houston, Children's Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). | Biotech Hunter | Biotech Hunter